文献
J-GLOBAL ID:202202226827339355
整理番号:22A0927381
エボラウイルス病発生の系統的レビューおよび2016年から2020年までの米国食品および薬剤投与によるエボラウイルス病治療に承認された新薬の有効性と安全性の分析【JST・京大機械翻訳】
A systematic review of Ebola virus disease outbreaks and an analysis of the efficacy and safety of newer drugs approved for the treatment of Ebola virus disease by the US Food and Drug Administration from 2016 to 2020
著者 (7件):
Sivanandy Palanisamy
(Department of Pharmacy Practice, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia)
,
Jun Pee Hui
(School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia)
,
Man Lai Weng
(School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia)
,
Wei Ng Sin
(School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia)
,
Mun Nicole Foo Kar
(School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia)
,
Yii Celestine Ang Jia
(School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia)
,
Ying Charissa Cheah Xiao
(School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia)
資料名:
Journal of Infection and Public Health
(Journal of Infection and Public Health)
巻:
15
号:
3
ページ:
285-292
発行年:
2022年
JST資料番号:
W3388A
ISSN:
1876-0341
資料種別:
逐次刊行物 (A)
記事区分:
文献レビュー
発行国:
オランダ (NLD)
言語:
英語 (EN)